Research Activities

Biomarker Discovery

The Biomarker Discovery Group provides detailed molecular signatures for NCEs under development and seeks to understand the biology of the drug intervention under respective disease conditions

Gene signatures and specific disease markers that are identified by microarray-based gene expression profiling are validated by approaches such as RTQ-PCR, immunohistochemistry, and gene knockout methods such as RNA interference.

The goal is to provide comprehensive support during the drug discovery and development lifecycle, with the following objectives:

• Drug efficacy predictions
• Validation of cell and animal models
• Clinical proof of principle
• Monitoring intervention
• Create scientific interest

 

Disease Areas of Research

Cancer

Inlammation

Diabetes